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Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic
disease caused by defective prelamin A processing, leading to nu-
clear lamina alterations, severe cardiovascular pathology, and pre-
mature death. Prelamin A alterations also occur in physiological
aging. It remains unknown how defective prelamin A processing
affects the cardiac rhythm. We show age-dependent cardiac repo-
larization abnormalities in HGPS patients that are also present in
the Zmpste24−/− mouse model of HGPS. Challenge of Zmpste24−/−
mice with the β-adrenergic agonist isoproterenol did not trigger
ventricular arrhythmia but caused bradycardia-related premature
ventricular complexes and slow-rate polymorphic ventricular rhythms
during recovery. Patch-clamping in Zmpste24−/− cardiomyocytes
revealed prolonged calcium-transient duration and reduced sarco-
plasmic reticulum calcium loading and release, consistent with
the absence of isoproterenol-induced ventricular arrhythmia.
Zmpste24−/− progeroid mice also developed severe fibrosis-unrelated
bradycardia and PQ interval and QRS complex prolongation. These
conduction defects were accompanied by overt mislocalization of the
gap junction protein connexin43 (Cx43). Remarkably, Cx43 mislocali-
zation was also evident in autopsied left ventricle tissue from HGPS
patients, suggesting intercellular connectivity alterations at late
stages of the disease. The similarities between HGPS patients and
progeroid mice reported here strongly suggest that defective cardiac
repolarization and cardiomyocyte connectivity are important abnor-
malities in the HGPS pathogenesis that increase the risk of arrhythmia
and premature death.
Hutchinson–Gilford progeria syndrome | progerin | prelamin A |
connexin43 | calcium handling
The LMNA gene encodes A-type lamins (lamin A and laminC), key components of the mammalian nuclear envelope with
important structural and regulatory functions that affect signaling,
transcription, and chromatin organization among other processes
(1). Mature lamin A is produced from the precursor prelamin
A through a series of posttranslational modifications, consisting
of sequential farnesylation at the cysteine in the Cysteine-Serine-
Isoleucine-Methionine motif, cleavage of the Serine-Isoleucine-
Methionine residues, carboxymethylation of the newly accessible
cysteine, and a final proteolytic cleavage by the zinc metal-
lopeptidase STE24 (ZMPSTE24, also called FACE-1) (2).
Mutations in the human LMNA gene or defective processing of
prelamin A cause a group of diseases termed laminopathies, includ-
ing the premature aging disorder Hutchinson–Gilford progeria syn-
drome (HGPS), a very rare genetic disorder with an estimated
prevalence of 1 in 21 million people (www.progeriaresearch.org).
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HGPS patients exhibit accelerated atherosclerosis and arterial
stiffness, leading to premature death at an average age of 14.6 y, pre-
dominantly from myocardial infarction, heart failure, or stroke (3,
4). Most HGPS patients carry a noninherited de novo heterozygous
synonymous mutation in the LMNA gene (c.1824C > T: GGC >
GGT; p.G608G), which activates the use of an internal 5′ splicing
site in exon 11 that causes the synthesis of progerin. This unpro-
cessed form of prelamin A lacks 50 amino acids encompassing
the ZMPSTE24 cleavage site and therefore, remains perma-
nently farnesylated (2). ZMPSTE24 mutations have also been
linked to several other human progeroid syndromes (5, 6),
reinforcing the notion that accumulation of progerin or prelamin
A accelerates cellular aging. Moreover, progerin and prelamin A
are both expressed in cells and tissues of normally aging non-
HGPS individuals, suggesting their involvement in physiological
aging (reviewed in refs. 2 and 7).
Genetically modified mice expressing prelamin A or progerin
have enabled the study of mechanisms underlying progeria (8)
and testing of the efficacy of various therapies (9, 10). Here, we
examined cardiac electrical alterations in 15 HGPS patients with
the classical LMNA c.1824C > T mutation, representing ∼5% of
the world population (www.progeriaresearch.org). We then corre-
lated the observed alterations in HGPS patients to the underlying
molecular processes in Zmpste24-null mice; these mice accumulate
farnesylated prelamin A in the nuclear envelope and phenocopy
several other defects observed in HGPS, including cardiovascular
alterations and premature death (average lifespan ∼20 wk vs. >2 y
in WT mice) (9, 11).
Results
Electrocardiographic Alterations in HGPS Patients. SI Appendix,
Tables S1 and S2 show electrocardiographic measurements from
HGPS patient carriers of the LMNA c.1824C > T mutation (n =
15, age range 2–19 y old) and controls (n = 13, age range 4–19 y
old), respectively. A glossary of electrocardiographic parameters
can be found in SI Appendix. As they aged, seven patients
showed overt repolarization abnormalities in at least one elec-
trocardiogram (ECG) that were compatible with coronary artery
disease (ST segment depression/elevation and negative and bi-
phasic T waves) (a representative example is in SI Appendix, Fig.
S1A). One patient showed significant QTc interval prolongation
(537 ms) in the context of ischemia at advanced stages of the
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Fig. 1. Age-related exacerbation of repolarization abnormalities in HGPS patients and Zmpste24−/− mice. (A, Left) Extracted averaged ECG leads II and V5
from human control participants (blue traces) and HGPS patients at initial stage (Initial; light red trace) and advanced stages (Last; dark red trace). (A, Right)
Quantification of mean flattening scores. (B, Left) Representative T-wave abnormalities in Zmpste24−/− mice comparing the first and the last isoproterenol
(ISO) challenge (SI Appendix, SI Materials and Methods). (B, Right) Mean effective flattening scores at baseline, after ISO exposure and during 5-min recovery.
*P < 0.05 vs. control; †P < 0.05 vs. first follow-up. First: 11-wk-old mice; Last: 19-wk-old mice or last week before death.
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disease (18 y of age). These alterations were not observed in
controls (a representative example is in SI Appendix, Fig. S1B).
Repolarization abnormalities in HGPS patients were highly ev-
ident at advanced disease stages. Compared with age-matched
controls, HGPS patients exhibited significant T-wave flattening,
which was exacerbated as disease progressed (Fig. 1A, initial:
initial ECG; last: last ECG during follow-up). All patients and
controls had sinus rhythm and normal PR interval and QRS
complex duration (SI Appendix, Tables S1 and S2). Interestingly,
although all HGPS patients exhibited cardiac rhythm within
physiological values, the heart rate and PR interval tended to be
slower and larger, respectively, in older HGPS patients (6 of 15)
at the end of the follow-up period (26.8 ± 2.3 mo follow-up):
heart rates on first and last ECGs were 114 ± 7 and 101 ± 7 beats
per minute (bpm), respectively, P = 0.36; PRs on first and last
ECGs were 115 ± 2 and 128 ± 11 ms, respectively, P = 0.22.
Time Course of ECG Abnormalities in Progeroid Zmpste24−/− Mice.
We next analyzed the electrocardiographic phenotype of
Zmpste24−/− mice, an established preclinical model of HGPS (9,
11). A glossary of electrocardiographic parameters can be found
in SI Appendix. To study repolarization, we quantified T-wave
flattening by measuring T-wave morphology changes, including
sharpness, by excess kurtosis of the T-wave peak in relation to its
geometrical change from the isoelectric line and the area under
the T wave (SI Appendix, SI Materials and Methods). Similar to
HGPS patients, progeroid mice showed repolarization abnor-
malities manifested as significant T-wave flattening. To deter-
mine the risk of ventricular arrhythmia associated with T-wave
alterations, we used the β-adrenergic agonist isoproterenol, which
can trigger calcium-related alterations in cardiac repolarization.
Weekly isoproterenol challenge, based on its sympathomimetic
effect and ability to induce Ca2+-related alterations in repolari-
zation, further exacerbated the repolarization alterations as
Zmpste24−/− mice aged, although acute isoproterenol did not
cause significant ventricular arrhythmias in Zmpste24−/− or
controls (Fig. 1B). Although both groups responded normally in
the first week of follow-up, older Zmpste24−/− mice developed a
very marked reduction in the heart rate (bradycardia) during
recovery from isoproterenol (Fig. 2A). In addition, compared
with WT controls, Zmpste24−/− mice progressively developed
longer RR intervals as they aged (Fig. 2 B and C). The variability
of the RR interval, measured as the SD, increased linearly as a
function of the average RR interval (SI Appendix, Fig. S2) and
was associated with increased incidence of premature ventricular
complexes (Fig. 2D and SI Appendix, Fig. S3) and a short lifespan.
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Fig. 2. Severe bradycardia in postisoproterenol (post-ISO) administration recovery is associated with an increase in premature ventricular complexes in
Zmpste24−/− mice. First: 11-wk-old mice; Last: 19-wk-old mice or last week before death. (A) β-Adrenergic response [interbeat interval (IBI)] in WT and
Zmpste24−/− mice from the first to the last ISO challenge. 95% CI, 95% confidence interval. (B) RR histograms in WT and Zmpste24−/− mice during ISO time
course challenge. The Insets show correlation plots between consecutive cardiac beats (RRn vs. RRn + 1; n = cardiac beat number within the entire registration
period; color-coded timescale). A significant increase in the percentage of long RR intervals during the last week of follow-up (C) was also associated with a
significant increase in bradycardia-related premature ventricular complexes (D). *P < 0.05; **P < 0.01 (SI Appendix, SI Materials and Methods).
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During both isoproterenol challenge (SI Appendix, Fig. S4) and
recovery (SI Appendix, Fig. S5), Zmpste24−/− mice showed in-
creased prolongation of PQ and QRS intervals. Progeroid
Zmpste24−/− mice also developed age-dependent bradycardia in
the absence of isoproterenol (Fig. 3A). In addition, at 18–20 wk of
age, Zmpste24−/−mice showed significant signs of defective cardiac
conduction compared with age-matched controls manifested as
prolonged PQ interval and QRS complex, without alterations to
the QTc interval (Fig. 3 B–E and SI Appendix, Table S3).
Preserved Cardiac Function in Zmpste24−/− Mice. Transthoracic
echocardiography revealed no abnormalities in left ventricle end
diastolic [left ventricular internal diameter at diastole (LVIDd)]
or left ventricle end systolic [left ventricular internal diameter at
systole (LVIDs)] parameters in progeroid Zmpste24−/− mice
(Fig. 3F). Likewise, Zmpste24−/− mice had normal left ventricle
mass, posterior wall and interventricular septal thickness at di-
astole (SI Appendix, Fig. S6A), and diastolic function but had a
slightly higher left ventricle ejection fraction (EF) and fractional
shortening than controls (Fig. 3F and SI Appendix, Fig. S6A),
although within the normal range. The higher EF in progeriod
mice might be explained by bradycardia, because longer diastolic
intervals may favor such an increase. In fact, together, bradycardia
and smaller body surface area in Zmpste24−/− mice explain the sig-
nificantly lower cardiac output compared with WT controls (SI Ap-
pendix, Fig. S6B). However, cardiac index, which relates the cardiac
output of the left ventricle per minute to body surface area, was not
different between progeroid and WT mice (SI Appendix, Fig. S6B).
Time course studies showed no between-genotype differences in
systolic or diastolic blood pressure (SI Appendix, Fig. S6C).
Ex Vivo Cellular Electrophysiology. We next conducted electro-
physiology studies in cardiac multicellular preparations from
Zmpste24−/− mice to identify potential mechanisms underlying
the arrhythmia risk associated with abnormal repolarization. No
significant between-genotype differences were found in resting
membrane potential, action potential (AP) amplitude, maximum
velocity of depolarization (Vmax), or AP duration in right or left
ventricular samples (SI Appendix, Table S4). Moreover, APs recor-
ded in right and left ventricular preparations were indistinguishable
between genotypes (Fig. 4A). Interestingly, most Zmpste24−/− ven-
tricular preparations exhibited slow spontaneous automatic activity
at ∼3 Hz (Fig. 4B). Also, Zmpste24−/− left ventricle preparations dis-
played afterdepolarizations that led to triggered APs, contrasting
with normal AP in controls (Fig. 4 B and C).
We next analyzed transcription of genes encoding ion channel
proteins involved in the different phases of the AP. Real-time
quantitative PCR (qPCR) analysis in Zmpste24−/− hearts
revealed no significant between-group differences in mRNA
expression of Scn5A (encoding the cardiac sodium channel
NaV1.5; involved in cell depolarization) or Kcna5, Kcnj2, Kcnd3,
and Kcnq1 (encoding the potassium channels Kv1.5, Kir2.1, Kv4.3,
and Kv7.1, respectively; all involved in AP repolarization); in
contrast, Zmpste24−/− hearts showed significant up-regulation of
Kcnh2 (encoding the potassium channel Kv11.1, also known as
human ether-à-go-go related gene (hERG; involved in AP repo-
larization) (SI Appendix, Fig. S7).
Zmpste24−/− Mice Show Defective Sarcoplasmic Reticulum Ca2+
Handling. We next investigated the role of intracellular Ca2+
handling in the observed in vivo afterdepolarizations and trig-
gered APs in multicellular left ventricle Zmpste24−/− prepara-
tions. Unlike WT cardiomyocytes, Zmpste24−/− cardiomyocytes
were unable to maintain stable Ca2+ transients at higher stimu-
lation frequencies, an effect that was more prominent at 5 mM
extracellular Ca2+ (Fig. 5A). To test whether this defect in
Zmpste24−/− cardiomyocytes was caused by unstable calcium
release from the sarcoplasmic reticulum (SR) through the ryano-
dine receptor type 2 (RyR2) channel, we measured the frequency
of spontaneous calcium waves at rest. However, we found no dif-
ferences in the calcium wave frequency at any of the calcium con-
centrations examined (Fig. 5B). In line with these results, Zmpste24
deficiency did not affect the transcript level of RyR2 (Fig. 5C),
which is responsible for calcium release from the SR (12).
These findings suggested possible impairment of L-type
Ca2+ currents (ICa) or Ca2+ uptake by the SR in Zmpste24−/−
cardiomyocytes as alternative causes for unstable calcium transients.
Compared with WT controls, Zmpste24−/− hearts expressed sig-
nificantly lower transcript and protein levels of SR Ca2+ ATPase,
whereas there was no alteration in transcript levels of STIM1
(stromal interaction molecule component of the store-operated
Ca2+ entry 1) and Orai1 (component of the store-operated Ca2+
entry), essential regulators of Ca2+ release-activated Ca2+
channels (Fig. 5 C and D). We also analyzed the expression of
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calsequestrin 1 (CSQ1) and CSQ2, calcium-binding proteins of
the SR that help this organelle store a very high amount of Ca2+
during relaxation in each contraction–relaxation cycle. Although
CSQ1 and CSQ2 transcript levels were significantly lower in
Zmpste24−/− hearts (Fig. 5C), no between-genotype differences
were observed at the protein level (Fig. 5D). Likewise, peak ICa
did not differ significantly between cardiomyocytes of the two
genotypes (SI Appendix, Fig. S8).
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To determine SR Ca2+ reloading function in ventricular car-
diomyocytes, we loaded the SR by exposing cells to an increasing
number of stimulation pulses and estimated the resulting Ca2+
load from caffeine-elicited inward current traces (Fig. 6A). SR
reloading function was significantly weaker in Zmpste24−/− car-
diomyocytes than in WT cells after 5, 10, and 20 stimulation
pulses (Fig. 6B), and the defective response was still more ap-
parent after ≥30 stimulation pulses (Fig. 6C). Significantly lower
SR Ca2+ loading in Zmpste24−/− cardiomyocytes was also evident
from caffeine-elicited current traces recorded after loading the
SR by depolarizing the membrane potential for 5 s to −40, −30,
−20, or 0 mV (Fig. 6 D and E). In addition, intracellular Ca2+
transients recorded in isolated cardiomyocytes paced at 0.5 Hz
revealed a significantly longer Ca2+-transient duration (at half-
maximal amplitude) in Zmpste24−/− cells (Fig. 6F).
Finally, we measured the SR Ca2+ release-dependent in-
activation of the ICa in response to consecutive stimulation pulses
given after clearance of SR Ca2+ (Fig. 7A) to assess the feedback of
SR calcium release on ICa inactivation. As expected, current traces
recorded in WT cardiomyocytes showed a faster rate of ICa in-
activation as the number of pulses used for SR reload increased
from 1 (p1) to 30 (p30) (Fig. 7B). In contrast, the effect of SR
loading on the ICa inactivation rate in Zmpste24−/− cardiomyocytes
was very modest (Fig. 7B). Accordingly, the time constant for ICa
inactivation decreased progressively with increasing pulse number
in WT but not Zmpste24−/− cardiomyocytes (Fig. 7C). Moreover,
the amplitude of the intracellular Ca2+ transient induced by re-
peated stimulation at 0.5 Hz was significantly lower in Zmpste24−/−
cardiomyocytes (Fig. 7D). Together, these findings indicate that SR
Ca2+ uptake and release are blunted in Zmpste24− /− car-
diomyocytes, which also explains the failure of acute isoproterenol
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treatment to induce ventricular arrhythmia, despite abnormal
repolarization.
Abnormal Connexin43 Localization in the Hearts of Zmpste24−/− Mice
and HGPS Patients. To further investigate conduction alterations
in progeria, we performed immunohistopathological studies in
heart tissue. Cardiomyocyte size was estimated by quantifying
their cross-sectional area in heart sections as well as the mem-
brane capacitance, which is linearly proportional to the plasma
membrane area and cell size. Because Zmpste24−/− mice are
smaller than age-matched controls (9, 11), we normalized results
by tibia length. Normalized cross-sectional area and membrane
capacitance were similar in cardiomyocytes of both genotypes (SI
Appendix, Fig. S9). We also performed Mallory’s trichrome
staining, which revealed normal chambers, ventricular walls, and
myocardial fiber arrangement in Zmpste24−/− hearts (SI Appen-
dix, Fig. S10 A and B). Moreover, Mallory’s trichrome staining
did not reveal increased fibrosis in the ventricular interstitium
(SI Appendix, Fig. S10B) or key structures involved in cardiac
conduction, such as the atrioventricular node and the main His
bundles (SI Appendix, Fig. S10C), which might have explained
conduction abnormalities in Zmpste24−/− mice. However, con-
sistent with previous studies in HGPS patients (13), Zmpste24−/−
mice showed extensive fibrosis in the tunica media of the major
coronary arteries (SI Appendix, Fig. S11A) and discontinuous
and weak expression of smooth muscle actin within the medial
arterial layer (SI Appendix, Fig. S11B).
Another possible explanation for the observed cardiac con-
duction anomalies is altered expression of intercalated disk
proteins that play a key role in intercellular connectivity, such as
the gap junction protein connexin43 (Cx43) and plakoglobin,
as well as cytoskeletal desmosome-interacting proteins, such as
desmin, a class III intermediate filament connected to A-type
lamins through Nesprin/Sun protein complexes. Western blot
analysis in progeroid hearts revealed a significant approximately
twofold increase in Cx43 expression without changes in plako-
globin or desmin (SI Appendix, Fig. S12). Remarkably, com-
pared with WT controls, Zmpste24−/− cardiomyocytes exhibited
marked mislocalization of Cx43 to the cytoplasm and the lateral
long axis as revealed by double immunofluorescence to simul-
taneously detect Cx43 and N-Cadherin (Fig. 8A). Quantification
of digital images revealed less Cx43/N-Cadherin colocalization in
the hearts of progeroid mice than in WT controls (Fig. 8E).
Profound Cx43 mislocalization was also revealed by immu-
nostaining of left ventricle specimens obtained from two HGPS
patients at autopsy. In these patients, Cx43 was abundantly as-
sociated with the perinuclear rim (Fig. 8 B–D), which is its
trafficking origin for subsequent targeting to the intercalated
disks (14) (Discussion). Quantification of digital images con-
firmed a low percentage of Cx43/N-Cadherin colocalization in
HGPS hearts (Fig. 8E). Defective cardiomyocyte connectivity
associated to Cx43 mislocalization may contribute to cardiac
conduction defects in progeria (Discussion).
Discussion
HGPS is a devastating genetic disease resulting from abnormal
processing of prelamin A, which is characterized by premature
cardiovascular disease and death at an average age of 14.6 y old
(4). Here, we provide a comprehensive analysis of electrocar-
diographic abnormalities and underlying molecular changes at
different stages of HGPS. Our findings may have implications for
the risk of premature death in HGPS patients and potentially,
normal aging, because defective prelamin A processing has also
been revealed in cells and tissues of normally aging non-HGPS
individuals (reviewed in refs. 2 and 7). A previous study identi-
fied repolarization abnormalities in 3 of 15 HGPS patients with
the “classical” LMNA c.1824C > T mutation (3). Here, we confirm
and extend these findings through a rigorous examination of a new
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cohort of 15 HGPS patients carrying the same mutation. One-half
of the patients showed overt repolarization abnormalities in at least
one ECG compatible with coronary artery disease (ST depression/
elevation and negative and biphasic T waves). Repolarization ab-
normalities in HGPS patients were strongly evident at advanced
disease stages. We also detected prominent mislocalization of Cx43
in left ventricle specimens obtained at autopsy from diseased
HGPS patients; Cx43 mislocalization was also observed in the
hearts of progeroid Zmpste24−/− mice and is indicative of defective
cardiac conduction in progeria (see below).
Animal models resembling the clinical phenotype of HGPS
patients are central to understanding the underlying mechanisms
of the disease and developing novel therapies. Our analysis
of the well-established Zmpste24−/− mouse model of progeria
caused by prelamin A accumulation (9, 11) revealed the pro-
gressive development of cardiac rhythm alterations that can lead
to premature death. Zmpste24−/− hearts and cardiomyocytes showed
the following specific alterations: (i) T-wave repolarization ab-
normalities, which were also present in one-half of HGPS pa-
tients; (ii) prolonged PQ interval and wide QRS complex;
(iii) development of bradycardia-related premature ventricular
complexes and slow-rate polymorphic ventricular rhythms at late
disease stages in the absence of ventricular arrhythmias during
isoproterenol challenge; (iv) automatic spontaneous ventricular
activity and afterdepolarizations ex vivo, which were associated
with significantly slowed ICa inactivation and reduced amplitude
of the intracellular Ca2+ transient; and (v) mislocalization of
Cx43 in the heart.
Notably, some characteristics of the progeroid Zmpste24−/−
mouse heart are also present in HGPS patients and frequently
observed in normal aging; these characteristics include extensive
fibrosis and loss of smooth muscle cells in coronary arteries,
defective calcium homeostasis, progressive development of re-
polarization defects, and Cx43 mislocalization (15–17). Overt
repolarization abnormalities in ST T waves and T-wave flatten-
ing in mice did not increase the risk of isoproterenol-triggered
ventricular arrhythmia. However, T-wave alterations are well-
known to increase the risk of lethal ventricular arrhythmias
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during ischemia (18), which might contribute to premature
death in HGPS patients from myocardial infarction, one of
the main causes of death in this population. T-wave abnor-
malities might be explained at least in part by an altered re-
polarization pattern brought about by two opposing ion channel
changes observed in the hearts of Zmpste24−/− mice: on the one
hand, the significant up-regulation of Kcnh2, which encodes
the hERG channel responsible for IKr, would help terminate the
AP plateau and shorten repolarization (19), and on the other
hand, the observed slow ICa inactivation would tend to prolong
the plateau and delay repolarization (20). Importantly, an ab-
normally long QTc interval was observed in only 1 of 51 ECGs
from 15 HGPS patients and occurred in the context of ischemia
and significant repolarization anomalies. Consistently, we ob-
served no significant QTc prolongation in Zmpste24−/− mice, in
agreement with the normal AP duration observed in Zmpste24−/−
ventricular cardiomyocytes and the majority of ECG traces from
HGPS patients. Although we documented significant QRS com-
plex widening in progeroid mice, it is important to note that the
high-amplitude QRS complex in the mouse ECG represents not
only the spread of depolarization across the ventricle but also, the
early phase of repolarization (21). We, therefore, carefully ex-
amined QRS complex and QT duration (QT90) (Fig. 3 B–E) to
detect any significant increases in both parameters. However,
mouse and human QT intervals must be compared with caution.
The occurrence of bradycardia-related premature ventricular
complexes in Zmpste24−/− mice during recovery after isoproter-
enol shows a significant suppression of normal pacemaker ac-
tivity, with emergence of ventricular ectopic escape discharges.
Isoproterenol-induced heart rate increase in vivo is associated
with increases in intracellular Na+ and Ca2+ concentration (22);
these changes, in the presence of the postisoproterenol-induced
bradycardia, likely contributed to the escape discharges and
premature ventricular complexes arising from the Purkinje sys-
tem (SI Appendix, Fig. S3). Our ex vivo experiments with mul-
ticellular ventricular preparations showed afterdepolarizations
during spontaneous ventricular activity at ∼3 Hz, which is similar
to the cycle length after isoproterenol treatment in vivo. Al-
though we were unable to establish the exact origin of these
ventricular afterdepolarizations, the in vivo data support involve-
ment of the Purkinje system, consistent with slow idioventricular
discharges (cycle length = 266.38) (SI Appendix, Fig. S3) arising
from varying Purkinje locations.
Connexins are the pore-forming subunits of gap junctions and
essential for proper intercellular electrical coupling between
cardiomyocytes and AP spread during each cardiac cycle (23,
24). Cx43 is the major connexin expressed in the ventricles. Its
abnormal expression, typically involving down-regulation and
heterogeneous redistribution to the lateral cardiomyocyte mem-
brane, is associated with different forms of chronic heart disease
(hypertrophic, dilated, and ischemic cardiomyopathy) and even
aging (24–26). Defective Cx43 expression results in electrical de-
fects in the myocardium and contributes to arrhythmogenesis.
Therefore, Cx43 mislocalization in the heart may explain, at least
partly, the prolongation of PQ interval and QRS complex in
Zmpste24−/− mice. Interestingly, reduced gap junction coupling
accompanied by Cx43 lateralization has been linked to reduced
functional expression of the alpha subunit (NaV1.5) of the cardiac
sodium channel at the intercalated disk (27), and the reduced
sodium current is likely to have contributed to the significantly
impaired atrioventricular and intraventricular conduction in
Zmpste24−/− mice. Previous computer simulations (28) suggest
that, even in the presence of Cx43 mislocalization and low NaV1.5
expression, a normal peak ICa with slow inactivation and reduced
Ca2+ transients could maintain relatively safe conduction in the
ventricles of Zmpste24−/− mice, albeit at a reduced velocity.
However, a high intracellular Ca2+ concentration would have
compromised propagation safety and caused earlier block as ob-
served for reduced intercellular coupling (28). Because the in-
tercalated disk is regarded as a functional unit, with gap junction
formation requiring the presence of neighboring mechanical
junctions (29), we tested the expression of desmin and plakophi-
lin-2. However, our Western blot analysis in Zmpste24−/− hearts
revealed no alterations in the expression of these proteins.
Consistent with the findings in Zmpste24−/− mice, immuno-
fluorescence studies in left ventricle specimens from deceased
HGPS patients revealed abnormal cellular distribution of Cx43
to a predominantly perinuclear localization. Because Cx43 is
packaged into vesicles at the perinuclear trans-Golgi network
and then transported to the intercalated disk (14), our findings
suggest that abnormal prelamin A processing causes defective
Cx43 targeting to its distinctive microdomain at the gap junctions.
Additional LMNAmutations might also cause cardiomyopathy by
altering connexin expression and/or cellular localization. For ex-
ample, transgenic mice expressing the lamin A N195K mutant,
which causes dilated cardiomyopathy with conduction system
disease in humans, die at an early age because of arrhythmia, and
such a phenotype correlates with cardiac Cx43 and Cx40 mis-
expression and/or mislocalization (30). Future studies are warranted
to elucidate the mechanism causing defective Cx43 microdomain
targeting to gap junctions and their contribution to abnormal cardiac
conduction in progeria.
Some of the nuclear envelope alterations in the heart associ-
ated with prelamin A or progerin expression also occur during
normal aging (15–17), suggesting that shared mechanisms might
cause cardiac alterations in HGPS patients and the geriatric
population. Consistent with this idea, prelamin A and progerin
are both produced in the cells of normally aging individuals, thus
raising the possibility that altered lamin A processing contributes
to normal aging and associated cardiovascular disease (reviewed
in refs. 2 and 7). Much like in normal human aging, progeroid
Zmpste24−/− mice develop coronary fibrosis, bradycardia, and
severe conduction abnormalities. Cardiac conduction abnormal-
ities also arise during aging in WT mice and are associated with
an increased incidence of arrhythmias (31). However, Ca2+
transients differ between Zmpste24−/− mice and normally aging
WT mice (32), with Zmpste24−/− cardiomyocytes being unable to
maintain stable Ca2+ transients at 4 Hz. Ventricular car-
diomyocytes from aged WT mice also have a significantly higher
incidence of spontaneous Ca2+ sparks than cells from young an-
imals; however, we did not observe a similar difference between
progeroid mice and age-matched controls. Zmpste24−/− mice
show weakened ICa inactivation and defective SR Ca2+ uptake
and release, features also observed in aging human atrial myo-
cytes (15). In line with these findings, Ca2+ transient amplitudes
are reduced in progeroid mice (Fig. 6), aged WT mice (32), and
aged human atrial cardiomyocytes (15).
The progressively developing bradycardia and deteriorating
cardiac conduction in progeriod mice also resemble clinical
rhythm abnormalities observed in the elderly (16, 17). Although
the most common age-related cardiac conduction abnormality in
humans is degenerative fibrosis (33), Zmpste24−/− mice did not
show abnormal fibrosis in the ventricular interstitium or the
major conduction structures. However, in line with observations
in HGPS patients (13), the coronary arteries of Zmpste24−/−
mice showed extensive fibrosis and reduced accumulation of
smooth muscle cells, potential causes of vascular stiffening, re-
duced coronary flow, and abnormal impulse generation in the
sinoatrial node and conduction in the atria and ventricles. The
latter may have also contributed to T-wave alterations, especially
during isoproterenol challenge, as well as progressive develop-
ment of bradycardia in progeroid Zmpste24−/− mice. In fact,
human patients with coronary artery disease show a high prev-
alence of conduction abnormalities, such as atrioventricular or
sinoatrial block (34).
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We provide a comprehensive characterization of cardiac ab-
normalities in HGPS patients and progeroid Zmpste24−/− mice,
identifying a number of cellular and molecular alterations in both
species that are likely to contribute to defective cardiac re-
polarization and conduction in progeria. Future studies are war-
ranted to establish direct causal connections between the presence
of unprocessed prelamin A or progerin and the cardiac abnor-
malities associated with HGPS, with the goal of identifying novel
targets for therapeutic intervention. Based on our findings, major
efforts should be placed into elucidating the mechanisms causing
Cx43 mislocalization in the heart of progeroid mice and HGPS
patients. These studies may pave the way to developing efficient
therapies to improve cardiac conduction in progeria.
Although ion channels are highly conserved between humans
and mice, significant electrophysiological differences exist (35),
making it difficult to translate mouse findings to the clinical
arena. For example, although we observed a tendency toward a
slower heart rate in older HGPS patients with longer follow-up,
HGPS patients did not show the bradycardia and other con-
duction abnormalities that appeared progressively in Zmpste24−/−
mice. This difference might be due to the lack of sequential ECG
assessment in humans until very advanced disease stages. Indeed,
human left ventricle specimens obtained by autopsy revealed re-
duced localization of Cx43 at gap junctions, consistent with altered
ventricular conduction velocity.
Continuous telemetry and other invasive electrophysiological
measurements would have been desirable in Zmpste24−/− mice.
However, these animals show severe body weight loss (body weight
of ∼9 g at late stages compared with ∼30 g in age-matched WT
controls) and are physically extremely fragile, precluding the use of
commercially available telemetry systems or any other invasive
approaches to register specific arrhythmias forecasting premature
death. The physical deterioration of HGPS patients also limits
implementation of any invasive measurements (e.g., implant-
able loop recordings) to further study rhythm abnormalities.
Materials and Methods
Clinical information from childrenwith HGPSwas obtained from The Progeria
Research Foundation Medical and Research Database (principal investigator
L.B.G.) and approved by the Rhode Island Hospital and Brown University
Institutional Review Boards (Providence, RI). All participants or parents
provided written informed consent in the primary language of the partici-
pant or parent. When appropriate, interpreters were used for consenting. At
least one ECG recorded no more than 3 y before death was obtained from
each of 15 HGPS patients. Thirteen gender- and age-matched control vol-
unteers were weighed, and ECG traces were recorded for comparison. All
control volunteers or parents provided written informed consent. Animal
studies were carried out in male Zmpste24−/−mice (11) and age-matched WT
male littermates (all C57BL/6). Mice were reared and housed in accordance
with institutional guidelines and regulations and all procedures with mice
were approved by the Centro Nacional de Investigaciones Cardiovasculares
Carlos III (CNIC) Ethical Committee. All other detailed materials and methods
are described in SI Appendix, SI Materials and Methods.
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GLOSSARY OF ELECTROCARDIOGRAPHIC PARAMETERS 
 
Bradycardia (in mice): A heart rate slower than normal average values in mice using the same 
protocol for anesthesia. Average heart rate in mice anesthetized with isoflurane (like in the present 
studies) has been previously reported at 450±17 bpm (1, 2), therefore bradycardia in our studies is 
considered at heart rates below such values. 
Bradycardia (in children >3 years of age): A heart rate <60 bpm. 
P wave: First positive deflection observed in the ECG, representing atrial depolarization. 
PQ interval: Time between the beginning of atrial depolarization and the beginning of ventricular 
depolarization. 
PR interval: Time from the onset of the P wave to the start of the QRS complex; it mainly reflects 
conduction through the AV node.  
Q wave:  Any negative deflection that precedes an R wave. 
QRS: Series of deflections in an electrocardiogram that represent electrical activity generated by 
ventricular depolarization. 
QT interval: Time from the start of the Q wave to the end of the T wave. 
QTc: Duration of the QT interval corrected for the patient’s heart rate.   
R wave: The initial upward deflection of the QRS complex, after the Q wave; it represents 
ventricular depolarization. 
RR interval: Time between two consecutive R waves in the electrocardiogram; it represents a 
complete cardiac cycle (patient’s heart rate).   
ST segment: The flat, isoelectric section of the ECG between the end of the S wave and the 
beginning of the T wave. 
T wave: Electrocardiogram deflection that represents the electrical activity produced by ventricular 
repolarization. 
 
  
3  
SI MATERIALS AND METHODS 
 
Electrocardiographic analysis of human ECG. Standard ECG recordings from human age- 
matched controls volunteers and HGPS patients were used to assess differences in repolarization 
abnormalities. Lead II and precordial V5 traces, commonly used for diagnosis of repolarization 
abnormalities (3) were selected to assess temporal and morphological differences between controls 
and patients, at the initial follow-up and advanced stages of the disease (last follow-up). 
A semi-automatic approach was used for digitization using a Matlab-based custom tool 
(Supplemental Figure S13), as previously described (4). Briefly, ECG recordings were scanned to 
a digital image (600 dpi) and stored in a codified digital format. To identify ECG traces on the 
standard ECG-paper, image-processing techniques were applied involving binary thresholding, pixel-
to-point conversion and transform techniques. When necessary, images were pre-processed to avoid 
artifacts (contrast, median filtering and interpolation) in the digitization process. Pixel-to-point 
conversion was applied using the lower waveform envelope. The graphical grid was used as reference 
for interpretation. 
 
Corrected QT interval (QTc) was calculated using Bazett’s formula, and considered prolonged when 
>450 ms for men and >470 ms for women (5). Age-dependent effects on human repolarization 
variability were quantified from averaged ECGs extracted from standard paper-ECG lead II 
(Supplemental Fig.S13). Human repolarization alterations were quantified using a rate-independent 
T-wave flattening score obtained from averaged area-normalized T-waves and compared with age-
matched controls (Supplemental Fig.S13) (6). The human T-wave Flattening Score was compared 
with ECG traces from age-matched healthy controls. The formulation applied is described below: 
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where T wave flatness is obtained for the unit area normalized T-wave. We used a modified and 
corrected peakedness factor described by the 4th central moment normalized to the variance. The score 
was corrected to allow increasing values of flatness reflect increasing values of flattening of the T-
wave. 
 
All data analyses, extraction and quantifications were done using custom scripts written in MATLAB 
software (version 8.1 release R2013a, The MathWorks Inc, Natick, Massachusetts, USA). 
 
Beat-to-beat variability of the RR interval series was primarily assessed using 2-dimensional 
representations of the pairs RRn-RRn+1 (n=cardiac beat number within the entire registration period) 
color-coded for time from blue to red. 
 
Time-course electrocardiographic analysis of mouse cardiac rhythm abnormalities. Mice were 
anesthetized with 1.5-2% isoflurane in oxygen, inhaled through a facial mask. To avoid night-day 
circadian variations, ECG was performed in the morning. ECG electrodes were inserted subcutaneously 
in the four limbs and sequential ECG recordings were acquired at 2 KHz sweep-speed using a MP36R 
data acquisition workstation (Biopac Systems). Data were stored for off-line analysis using custom 
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MatLab scripts. From 11 weeks of age (First week) until 19 weeks of age or death of the animal (Last 
week), Zmpste24-/- and wild-type mice were given weekly β-adrenergic challenge with isoproterenol 
(i.v. bolus 0.34 mg/kg). ECG traces were recorded at baseline, after challenge, and during recovery 
(10 to 25 min). 
  
ECG recordings were analyzed offline using custom scripts for pre-processing, visualization and 
quantification of electrophysiological intervals and heart rate variability markers. After band-pass 
filtering between 0.5-250 Hz, baseline wander was removed using a bidirectional filtering strategy. 
Baseline drift removal is essential for morphological analysis of T-waves. Supplemental Figure S4 
shows averaged ECG from WT and Zmpste24-/- mice obtained after Q-wave alignment from up to 
100 beats in mice at baseline, prior to E-adrenergic stimulation. Specifically: i) PR intervals were 
measured from the beginning or the P wave to the peak of the R wave; ii) QRS intervals were 
measured from the beginning of the Q wave until the point where the S wave crosses the baseline; 
and iii) QT intervals were measured from the beginning of the Q wave until the point where the T-
wave declines to 90% (T90) from the peak (7). Finite differential methods and wavelet transform were 
used for fiducial point estimation. R-peak detection was robustly estimated by parabolic fitting of the 
coiflet wavelet transform and detection of the maximum magnitude point. All R detections were 
supervised to ensure accuracy of ECG segmentations. After QRS detection, P and T wave segments 
were extracted using adaptive windowing depending upon beat-to-beat RR changes. After 
segmentation using differential methods, both waves were low-pass filtered at 20 Hz using a Kaiser 
window FIR filter.  
 
Adaptive heart-rate-corrected QT values (QTc) were derived using a modification of Bazzet’s 
formula for murine electrocardiography (8). RR and QTc dispersion were assessed as the difference 
between the maximum and minimum intervals measured. Up to 5 minutes of recordings, aligned to 
the Q-wave, were used to obtain signal-averaged ECG (SAECG) traces, where additional 
electrophysiological parameters were quantified for data analyses. Quantified variables were mean 
P-wave duration, QRS duration, T-wave duration and dispersion, Q-wave to Tpeak, and Tpeak to T90 
(90% of repolarization from Tpeak) (not shown). All measured intervals were based on previous studies 
in murine electrophysiology (9).  
 
T-wave morphological alterations were quantified by defining a modified flattening kurtosis-based 
descriptor derived for mice (6) (Supplemental Figure S14). T-wave SAECG in each segment of 
interest (up to 5 minutes, 2143±274 complexes) was considered for T-wave parameterization. 
SAECG traces were appropriately de-trended and rectified to determine the T-wave onsets. T-wave 
offset was determined as the 90% repolarization from the T-wave peak (T90). T-wave end (Tend) was 
defined as the maximum change in slope during recovery to the isoelectric line. T-waves were 
interpreted as unit-area normalized probability density functions (TPDFs) for kurtosis estimation to 
describe the peakedness of the distribution as compared to a Gaussian distribution function. The 
flattening score was defined as the product of a geometric factor multiplied by the inverted normalized 
kurtosis corrected to achieve increasing values of flattening score with increasing flatness of the T-
wave. The equation applied is:  
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where the peakedness factor is described by the central moments used to obtain excess kurtosis 
(fourth central moment normalized to the squared second moment) of the TPDFs were calculated as 
described elsewhere (10). A geometrical correction factor includes Td and Tp-To as the averaged T-
wave duration and the T elevation from the isoelectric line. AT represents the area prior to 
normalization and dTdtmax the T-wave upstroke depolarization. Supplemental Figure S14 shows 
representative traces of SAECGs with corresponding segmented T-waves and flattening score values 
for Zmpste24-/- and wild-type mice in each segment of interest for the initial (First; 11 week) and 
last week of follow-up. 
All the above-described ECG measures were quantified in Zmpste24-/- mice and controls at baseline 
(1 minute), after ß-adrenergic stimulation to exacerbate the Zmpste24-/- phenotype (5 minutes), and 
during recovery (4 minutes). Any premature ventricular complexes (PVC) or spontaneous 
ventricular rhythms were quantified and classified as isoproterenol-related or bradycardia-related. 
Heart rate variability analysis in mice. We quantified short and mid-term heart rate variability 
(HRV) markers from ECG recordings of up to 25 min. Time domain, frequency domain geometrical 
and non-linear standard HRV descriptors (11) were automatically quantified using custom scripts in 
Matlab. All R-waves detected were considered for the offline heart rate variability analysis. A mean 
of 5739±1402 complexes was considered in each animal. Time domain descriptors included the 
mean and standard deviation of the RR interval series, as well as descriptors for quantification of 
beat-to-beat rate differences. 
Mouse transthoracic echocardiography. Two-dimensional and M-mode echocardiography studies 
were performed weekly in anesthetized mice (1.5-2% isoflurane in a mixture with oxygen by a facial 
mask) using a Vevo 770 system (VisualSonic) equipped with a 30-MHz linear transducer probe. To 
avoid night-day circadian variations, echocardiography was performed in the morning. Before 
echocardiography, animal fur was removed with a topical depilatory agent and animals were warmed 
to maintain body temperature. The heart was imaged in the 2D parasternal long- and short-axis 
projections with guided M-mode recordings at the midventricular level in both views. LV end-
diastolic diameter (LVEDD), LV-systolic diameter (LVESD), end-diastolic LV anterior wall 
thickness (LVAW), and LV posterior wall thickness (LVPW) were measured from images obtained 
by M-mode echocardiography. LV fractional shortening (FS) was calculated as follows: 
FS (%) = [(LVEDD-LVESD)/LVEDD][100].  
LV ejection fraction (EF) and LV mass were calculated as follows: 
EF (%) = [(LVEDD3-LVESD3)/LVEDD3][100] 
LV mass (mg) = [1.053][(LVEDD + LVAW + LVPW)3 – (LVEDD)3] 
 
Blood pressure measurements in mice. A noninvasive automated tail-cuff device was used 
(Visitech System BP2000, NC). Mice were trained on a daily basis for one week, and weekly 
measurements were made at the same time in the morning. For greater accuracy, the first 10 of 20 
measurements were discarded, and mean of the last 10 measurements were used for analysis. 
Histomorphologic characterization of mouse heart. Zmpste24-/- and wild-type hearts were fixed 
in 4% paraformaldehyde, embedded in paraffin, sectioned with a microtome (10µm) and mounted 
on poly-L-lysine-coated glass slides. Routine histological analysis was performed using picrosirius 
red and Mallory’s trichrome staining. 
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Coronary artery fibrosis was quantified in Mallory’s trichrome-stained sections from 5 animals of 
each genotype. Large caliber arteries at the interventricular septum and free ventricular walls were 
identified and 3 transverse arterial profiles photographed along a total length of 300-400 µm (a 
minimal distance of 30 µm between sections was observed). Fibrosis was plotted against the total 
surface of the arterial medial wall using Adobe Photoshop, and the percentage of fibrotic pixels with 
respect to the total arterial surface was calculated with FiJi software. Statistical significance was 
assessed using t-Student’s test by separately comparing each mutant specimen with a matched 
control, as well as by comparing pooled data from all mutants and wild-type specimens. 
To quantify cardiomyocyte size, Mallory’s-trichrome-stained left and right ventricular sections from 
4 mice of each genotype were photographed with a NIKON DXM1200 camera. The profiles of 
individual cardiomyocytes were manually defined using Adobe Photoshop. The total area of each 
cardiomyocyte cross section (as an estimate of cell diameter/minor axis) was plotted as a black 
domain on a white background. Ninety cardiomyocytes were analyzed per ventricle (right/left) and 
specimen. NIH ImageJ software was used to quantify the total number of pixels per discrete black 
area (cardiomyocyte surface) in mice of both genotypes.  
 
Autopsy specimens. Paraffin-embedded autopsy left ventricle specimens from HGPS patients 
HG028 and HG120 were obtained from the Cell and Tissue Bank of the Progeria Research 
Foundation (Rhode Island Hospital, Providence, RI) 
(www.progeriaresearch.org/cell_tissue_bank.html). Tissues were fixed in 2% paraformaldehyde 
and embedded in paraffin. Mutational analysis via the PRF Diagnostics Program 
(www.progeriaresearch.org/diagnostic_testing.html) identified the LMNA c.1824C>T mutation in 
both patients. 
Immunohistochemistry. Mouse heart sections were immunostained using primary antibodies 
against smooth muscle α-actin (SMα-actin; SIGMA). Sections were dewaxed and rinsed with PBS. 
Endogenous peroxidase was quenched with 6% H2O2 and specimens were blocked in 1% BSA + 5% 
goat serum + 0.1% Triton X-100 for 3 h at room temperature. Slides were then incubated with 
primary antibody diluted in PBS (overnight, 4ºC), washed in PBS, and incubated with biotinylated 
anti-mouse smooth muscle α-actin for 3 h at room temperature. After washing in PBS, the samples 
were incubated in HRP-conjugated ExtrAvidin (SIGMA), and peroxidase activity was developed 
using the SIGMA Fast kit (Urea buffer + DAB). After final washes in water, specimens were 
dehydrated and mounted in DePeX (VWR BDH) for light microscopy inspection. 
Double immunostaining for connexin 43 (Cx43) and N-cadherin (N-Cadh) was performed in left 
ventricular transverse-sections (10µm) from mice and HGPS patients HG028 and HG120 (see above 
“Autopsy specimens”). Antigens were retrieved by heating in TEG buffer (25 mM Tris-HCl pH 8, 
10 mM EDTA 50 mM glucose) in a pressure cooker. Before primary IgG incubation, endogenous 
biotin was blocked using an avidin/biotin blocking kit (Vector Laboratories). Non-specific IgG 
binding was blocked with SBT solution (5% goat serum, 1% BSA and 0.5% Triton X-100 in Tris-
PBS). Samples were incubated overnight (4ºC) with anti-Cx43 (1:50 in SBT, ABNOVA Anti-GJA1) 
and anti-NCadh (1:50 in SBT, DSHB-MNCD2). After extensive washes with PBS, sections were 
incubated for 2 h with biotinylated anti-rabbit IgG (1:100 in PBS), washed again in PBS, and 
incubated in TRITC-coupled extravidin and anti-mouse FITC for 2 h at room temperature. After 
final PBS washes, cell nuclei were counterstained with DAPI (1:2000 in PBS) and slides were 
mounted in Glicerol/PBS (1:1). Samples were visualized with a SP5 laser confocal microscope 
(LEICA). 
Quantification of Cx43 mislocalization in heart sections. Image analysis of raw 
inmunohistochemical fluorescently-labeled mouse and human heart sections was performed to 
accurately quantify Cx43 localization at the intercalated disks. Extracted hyperstacks were separated 
into independent channels prior to image pre-processing. Two-dimensional median filtering with a 
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5x5 neighborhood was applied to minimize salt-and-pepper background noise. Semi-automatic 
segmentation by multidimensional histogram thresholding based on pixel intensities was applied to 
obtain binary feature extracted images and was corrected if necessary to optimize levels within each 
channel across heart sections. Additional morphological operations were applied for each individual 
binary mask, including filling, erosion and dilatation with a disk-shaped structuring element of radius 
= 4 pixels neighborhood to remove false positives. Detected blobs were delineated using a 
connectivity kernel of 8 pixels and used for binary image operations to determine staining and 
determine % co-localization among staining channels. A circularity score was defined as previously 
validated using ImageJ software (12). Cx43 was considered to be accumulated laterally when not co-
localizing with the intercalated disks (N-Cadh) or internalized near the nuclei (co-localizing with 
DAPI), which simultaneously presented high (>0.5) circularity scores. All automatically segmented 
images were inspected by two independent investigators to validate the methodology.  
 
Quantitative real-time PCR (qPCR). Total RNA was extracted from mouse heart apex tissue using 
QIAzol reagent (QIAGEN). cDNAs were synthesized using the SuperScript III First- Strand 
Synthesis System for RT-PCR (Invitrogen) and oligo dT primers. cDNA amounts were determined 
by qPCR using SYBR green qPCR Mix (Applied Biosystems). PCR conditions for amplification of 
all genes were 1 min at 95ºC and 40 cycles of 95ºC for 30 s, 57ºC for 30 s, and 72ºC for 30 s. 
Specificity of the SYBR green assays was confirmed by melting-point curve analysis. Expression 
data were calculated in qBASE from the cycle threshold (Ct) value using the ΔΔCt quantification 
method. Gene expression of 18S rRNA and GAPDH were used for normalization. Primers used for 
amplification are as follows:  
 
GENE Forward (5’ – 3’) Reverse (5’ – 3’) 
Orai1 AACGAGCACTCGATGCAGG GGGTAGTCATGGTCTGTGTCC 
STIM TGACAGGGACTGTACTGAAGATG TGCCGAGTCAAGAGAGGAGG 
CSQ1 CTCATCAGCAGAAGGCAGGT TTGACCTGTCAGCTCCACAA 
CSQ2 TGCTCATGGTGGGGGTTTATC AGGTTCGTGGTAATAGAGACAGA 
SERCA2a GAGAACGCTCACACAAAGACC ACTGCTCAATCACAAGTTCCAG 
RyR2 GCAGTCCCTGTCAGTACGG CGTGTCCATAGAGGAGTGTCC 
SCN5A ATGGCAAACTTCCTGTTACCTC CCACGGGCTTGTTTTTCAGC 
KCND3 CCGGTCCCTGTGATAGTCTC AGGGGATCATCCACAAGATAGG 
KCNQ1 CGCGGTGGTCAAGAAGTGT CACTGTAGATGGAGACCCG 
KCNJ2 ATGGGCAGTGTGAGAACCAAC TGGACTTTACTCTTGCCATTCC 
KCNH2 GTGCTGCCTGAGTATAAGCTG CCGAGTACGGTGTGAAGACT 
KCNA5 TCCGACGGCTGGACTCAATAA CAGATGGCCTTCTAGGCTGTG 
 
 
Western blot. Mouse hearts were dissected, extensively washed with PBS and immediately snap-
frozen in liquid nitrogen until further use. The hearts were ground with a mortar while frozen, further 
disrupted with TissueLyser (QIAGEN), and homogenized after incubation for 30 min at 4ºC with 
gentle rocking in lysis buffer (50 mM Tris-HCl pH 7.5; 0.1 M NaCl, 1 mM MgCl2, 1 mM DTT, and 
2% TX-100) supplemented with phosphatase and protease inhibitor cocktails (Roche). Protein 
concentration was determined by the Bradford assay (Protein Assay Kit, Bio-Rad). Cell extracts were 
preserved at -80ºC until use. For protein analyses, total protein extracts (40 µg) were mixed with 
Laemmli sample buffer (62.5 mMTris-HCl, pH 6.8, 2.3% SDS, 10% glycerol, 5% β-
mercaptoethanol, 0.005% bromophenol blue), boiled for 10 min, and resolved on 10-12% SDS-
polyacrylamide gels. Proteins were transferred to PVDF membranes using the iBlot Dry Blotting 
system (Invitrogen). Membranes were incubated for 1 h at room temperature in blocking buffer (5% 
non-fat dried milk in TBS, 0.2% Tween-20) followed by incubation with primary antibodies diluted 
in blocking buffer (overnight, 4ºC). Primary antibodies were purchased from Sigma-Aldrich (anti-
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tubulin, ref. T9026), Invitrogen (anti-Cx43, ref. 71-0700), Abcam (anti-desmin, ref. ab8592; anti-
CSQ, ref ab3516), Beckton Dickinson (anti-plakoglobin; ref BD610253), and Santa Cruz 
Biotechnology (anti-Serca2, ref sc8095). After washes with TBS, 0.2% Tween-20, membranes were 
incubated with appropriate HRP-conjugated secondary antibodies (Santa Cruz) for 1 h at room 
temperature, and specific proteins were visualized by enhanced chemiluminescence (GE 
Healthcare).  
To quantify relative protein levels in heart, western blots were performed with heart extracts from 3 
wild-type and 3 Zmpste24-/- mice. The intensity of protein bands was determined by densitometric 
analysis of independent blots for each lysate (2 blots for plakoglobin and SERCA2 and 3 blots for 
desmin, Cx43, and CSQ). Protein abundance was normalized to the intensity of the tubulin loading 
control. Mean values were first calculated for the methodological replicates from the 2-3 independent 
blots. These values were then used to calculate the overall mean value for each genotype. Results are 
presented as mean±SEM (relative to wild-type=1).  
Action potential (AP) measurements in mouse ventricular preparations. Transmembrane APs 
were recorded in ventricular preparations from male wild-type and Zmpste24-/- mice using glass 
microelectrodes filled with 3 M KCl (tip resistance: 8-15 M:) (13). Multicellular preparations were 
perfused with a modified Tyrode’s solution containing (in mM): NaCl 125, KCl 5.4, CaCl2 1.8, 
MgCl2 1.05, NaHCO3 24, NaH2PO4 0.42 and glucose 11. The solution was bubbled with 95% O2 and 
5% CO2 (pH=7.4) and maintained at 34qC.  The microelectrode was connected with Ag-AgCl wire   
to high-input impedance, capacity-neutralizing amplifiers (model 701; WPI, New Haven, CT, USA). 
Left ventricular preparations were stimulated using rectangular pulses (duration 1-2 ms) at a 
frequency of 3 Hz delivered from a multipurpose programmable stimulator (CS-220; Cibertec SA, 
Madrid, Spain). APs were computer stored using Acknowledge software. Recordings from at least 
three stable microelectrode impalements were stored for each preparation. 
 
Intracellular calcium measurements in isolated mouse cardiomyocytes. Ventricular 
cardiomyocytes were isolated from mouse hearts by enzymatic digestion. Briefly, the heart was 
mounted on a Langendorf perfusion system and perfused at a constant flow rate of 3 ml/min. The 
heart was first perfused for 5 min with nominally calcium-free Tyrode’s solution containing (in mM): 
NaCl 88, sucrose 78, KCl 5.4, MgCl2 1, HEPES 10, Na-pyruvate 5 and glucose 10 plus 2 mg/ml 
BSA. Subsequently, atria were removed and ventricles were digested for 8 min with nominally 
calcium-free Tyrode’s solution containing collagenase (0.4 mg/ml, Worthington type II). To increase 
cardiomyocyte yield, additional digestion was carried out for 5 min in collagenase-containing 
calcium-free Tyrode’s solution with gently agitation. This process was repeated three times and 
desegregated cardiomyocytes were pooled in a solution in which extracellular calcium concentration 
was increased stepwise to 0.2, 0.4, and 0.8 mM. Cardioyocytes were then stored at room temperature 
and those showing elongated and striated features were used for electrophysiological, calcium 
imaging and immunofluorescent labelling studies. 
Confocal Ca+2 imaging was performed in fluo-4 loaded ventricular cardiomyocytes using a Leica 
TCS SP5 resonance scanning confocal microscope equipped with a 63X 1.3 NA glycerol objective. 
Fluo-4 was excited at 488 nm and fluorescence emission was measured between 500 and 650 nm in 
the frame scanning mode (14). Calcium transients were recorded at room temperature (20-22oC) and 
elicited by subjecting cardiomyocytes to electrical field stimulation (5 ms pulses, 5-15 V) at 
increasing stimulation frequency (0.5 to 4 Hz). Calcium transients and spontaneous calcium waves 
were automatically detected and quantified using custom-made programs (15). 
 
Perforated patch-clamp in mouse ventricular cardiomyocytes. Ionic currents in ventricular 
cardiomyocytes were measured with the perforated patch-clamp technique (16). L-type calcium 
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currents were elicited by a 100 ms depolarization to 0 mV from a holding potential of -80 mV. Na+-
currents were eliminated by inclusion of 30 µM tetrodotoxin in the bath solution and a 50-ms 
prepulse from -80 to -50 mV. Transient inward currents were measured with the holding potential 
clamped at -80 mV for 30s. The amount of calcium released from the SR was measured by rapid and 
transient treatment with 10 mM caffeine (with the membrane potential clamped at -80 mV during 
the 5 s of caffeine application) followed by integration of the elicited inward current. 
Statistical analysis. Data are presented as mean ± SEM. Statistical significance was assessed by 
unpaired two-tailed t-test for comparisons involving two groups, or one-way ANOVA followed by 
Newman–Keuls post-hoc test for multiple comparisons. Statistical significance was assigned at 
p<0.05. 
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SUPPLEMENTAL FIGURES 
                  
 
 
 
 
FIGURE S1. Electrocardiogram and rhythm strips in human subjects. Shown are 
representative 12-lead ECG recordings acquired at 25 mm/s. (A) Female HGPS patient 
(DB296; ECG #6) showing repolarization abnormalities such as negative and biphasic T 
waves (*), ST depression (§) and ST elevation (#). (B) Electrocardiogram tracing from a 
representative gender and age-matched healthy control (ID1) 
12  
 
 
 
 
FIGURE S2. Linear increase of the R-R interval from the first to the last week of follow-up 
in Zmpste24-/- progeroid mice. WT and Zmpste24-/- mice were given weekly β-adrenergic 
challenge with isoproterenol starting at 11 weeks of age (First) and until 19 weeks of age or death 
of the animal (Last). Averaged RR and standard deviation RR (SD-RR) are shown in milliseconds 
(ms). The discontinuous line shows time progression as disease progresses from first week of 
follow up (11-13-week-old mice) until week 19 of age or death.
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FIGURE S3. Zmpste24-/- mice develop premature ventricular complexes (PVC) and slow-
rate polymorphic ventricular rhythms. Representative ECG traces and rhythm profiles 
recorded in lead aVF before (A), after (B) and during recovery (C) of Zmpste24-/- mice from 
isoproterenol challenge at the last week of follow-up. Arrowhead indicates premature ventricular 
complexes. Different ventricular morphologies are indicated by numbers. At the beginning of the 
trace a pseudo-regular ventricular morphology seems to be present. 
14  
 
 
 
 
FIGURE S4. PQ and QRS abnormalities observed after isoproterenol bolus. WT and progeroid 
Zmpste24-/- mice were given weekly β-adrenergic challenge with isoproterenol starting at 11 weeks of 
age (First) and until 19 weeks of age or death of the animal (Last). (A) PQ and QRS quantification 
observed after the first isoproterenol challenge and after the last follow-up challenge. (B) 
Representative superimposed traces color-coded for time from blue to red, illustrating the time course 
of ECG changes in this period.  
*, p<0.05; **, p<0.01; ***, p<0.001 (WT vs Zmpste24-/-) . 
#, p<0.05 (First vs Last week of follow-up). 
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FIGURE S5. PQ and QRS abnormalities observed during recovery from isoproterenol. WT and 
progeroid Zmpste24-/- mice were given weekly β-adrenergic challenge with isoproterenol starting at 
11 weeks of age (First) and until 19 weeks of age or death of the animal (Last). (A) PQ and QRS 
quantification observed during recovery after the initial first   isoproterenol challenge and the last 
follow-up challenge. (B) Representative superimposed traces color-coded for time from blue to red, 
illustrating the time course of ECG changes in this period.           
*, p<0.05; **, p<0.01; ***, p<0.001 (wild-type vs Zmpste24-/-).  
#, p<0.05 (First vs Last week of follow-up). 
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FIGURE S6. Progeroid Zmpste24-/- mice have preserved cardiac function and normal blood 
pressure. (A, B) Mice of both genotypes (18-20 weeks of age) were examined by trans-thoracic 
echocardiography to quantify LV posterior wall and interventricular septum thickness measured 
at diastole (LVPWd and IVSd, respectively), and LV mass. All LV parameters were corrected by 
tibia length. LV function is shown as fractional shortening (FS). Cardiac output (systolic volume 
x heart rate) and cardiac index (µl/min/cm2) were also quantified. (C) Longitudinal analysis of 
mice of the indicated ages revealed no differences in blood pressure. 
 
**, p<0.01; ***, p<0.001. 
  
17  
A B
INa 
Mice Action Potential 
Li-Smidth et al 2009  
Gene Current 
Am
pli
tu
de
 (m
V)
 
SCN5A 
KCNA5 
KCNH2 
KCNQ1 
KCNJ2 
IKur 
IKr 
IKs 
IK1 
KCND3 Ito 
Wild-type (n=6)
Zmpste24-/- (n=6)
Mouse Action Potential
 
FIGURE S7. Expression of cardiac sodium and potasium channels in WT and Zmpste24-/- 
mice. (A) Real-time qPCR analysis in heart tissue from 16-18-week-old mice to examine mRNA 
levels of ion channels involved in the different phases of the action potential (see B). The graphs 
show relative mRNA transcript expression of the indicated sodium channel (Scn5a) and 
potassium channels (Kcna5, Kcnd3, Kcnj2, Kcnq1, Kcnh2). Results (Ct values) of triplicate 
samples from wild-type and progeroid Zmpste24-/- mice (n=6 per genotype) were normalized 
against 18S RNA and are presented as mean±SEM (relative to WT=1). *, p<0.05. (B) 
Representative mouse action potential obtained by computer simulation using the validated model 
reported by Li et al. (17), showing the participating ionic currents and their relation to the genes 
examined in this study. Elevated Kcnh2 mRNA levels in Zmpste24-/- mice may explain the altered 
regulation of Ikr (rapidly-activated repolarizing potassium current), which might contribute to 
cardiac repolarization abnormalities. 
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FIGURE S8. L-type calcium current is not significantly altered in Zmpste24-/- ventricular 
myocytes. (A) L-type calcium current traces recorded in myocytes stimulated at 0.5 Hz. (B) 
Average ICa amplitude in isolated myocytes stimulated continuously at 0.5 Hz. (C) ICa-voltage 
relationship recorded in the same myocytes. 
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FIGURE S9. Cardiomyocyte size in wild-type and Zmpste24-/- mice. (A) Transverse sections of 
ventricular tissue of WT (n=4) and Zmpste24-/- (n=4) mice were stained with Mallory’s trichrome 
or anti-laminin antibodies and digital images were analyzed with Adobe Photoshop to define the 
profiles of individual cardiomyocytes. Top:  Representative examples of cardiomyocyte profiles. 
The total area of each cardiomyocyte cross section (as an estimate of the diameter/minor axis of 
the cells) was plotted as a black domain on a white background. Bottom: The profiles of 90 
cardiomyocytes per ventricle (left and right) were analyzed with NIH J software to quantify cell 
surface (average number of pixels per cardiomyocyte). Graph bars indicate averaged number of 
pixels per cardiomyocyte normalized by tibia length. (B) Membrane capacitance of ventricular 
cardiomyocytes determined by patch-clamp was normalized by tibia length. Values are from n=23 
cardiomyocytes from 10 Zmpste24-/- mice and n=39 cadiomyocytes from 12 WT mice. Results 
were normalized by tibia length because Zmpste24-/- mice are significantly smaller than age-
matched WT controls. pF: picofarads. 
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FIGURE S10. Immunohistopathological characterization of the heart of progeroid 
Zmpste24-/- mice. Heart cross-sections from mice at 18-20 weeks of age were stained with 
Mallory’s trichrome. Five mice of each genotype were analysed and representative examples are 
shown. (A, B) Gross examination revealed normal morphology and myocardial fiber arrangement 
in the progeroid heart. Interstitial fibrosis was negligible in both genotypes. (C) Absence of 
fibrosis in the cardiac conduction system of progeroid Zmpste24-/- mice. Magnified views of 
selected areas are shown. Arrowheads indicate the atrio-ventricular node.  
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FIGURE S11. Abnormal coronary artery fibrosis in progeroid Zmpste24-/- mice. (A) To 
quantify coronary artery fibrosis, Mallory’s trichrome-stained sections were analyzed (n=5 mice 
of each genotype). Large calibre arteries at the interventricular septum and free ventricular walls 
were identified and 3 transverse arterial profiles photographed along a total length of 300-400 µm 
(a minimal distance of 30 µm between sections was observed). Fibrotic and non-fibrotic areas in 
the vessel wall were projected using Adobe Photoshop (black: fibrotic area; red: non-fibrotic area), 
and the percentage of fibrotic pixels with respect to the total arterial surface was calculated with 
FiJi software. (B) Loss of smooth-muscle α-actin expression in the major coronary vessels of 
Zmpste24-/- mice.  
 
***, p<0.001. 
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FIGURE S12. Increased expression of connexin 43 in hearts of progeroid Zmpste24-/- mice. 
(A) Representative western blots of gap junction proteins (connexin 43 and plakoglobin) and 
desmosome-interacting protein (desmin) in WT and Zmpste24-/- hearts (n=3 per genotype). 
Tubulin was used as a loading control. (B) Quantification of relative protein expression in 
progeroid mice, normalized to WT.  
 
*, p<0.05. 
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FIGURE S13. Extraction of electrocardiograms in human subjects. Representative 12-lead 
ECG recordings and extracted lead-II ECG acquired at 25 mm/s (controls in black and HGPS 
patients in gray). (A) Segmented and digitized traces. (B) Digitized signal (5-s segments) and 
averaged ECG calculation for feature extraction. 
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FIGURE S14. Sample measurement for mouse T-wave flattening estimation from 
normalized signal-averaged ECGs (SAECGs). (A) Segmented T-waves from T-onset to T90 and 
estimated flattening score, kurtosis and area under the T-wave. Increasing values of kurtosis and 
area under the T-wave correlate with decreasing values of flattening score in each time period. (B) 
SAECG traces obtained at baseline (immediately before isoproterenol), after isoproterenol, and 
during recovery. WT and Zmpste24-/- traces are color-coded in blues and reds, respectively, from 
light (initial) to intense (last week of follow-up).
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TABLE S3. Surface ECG analyses comparing fundamental rhythm parameters between WT 
and Zmpste24-/- mice 
 
 
 
Wild-type (n=6) Zmpste24-/- (n=6) 
Parameters (ms) Baseline ISO Recovery Baseline ISO Recovery 
First week of Follow-Up 
 
RR 155.85 ± 13.52 131.99 ± 7.23 136.98 ± 4.43 176.73 ± 20.08 136.08 ± 7.22† 210.68 ± 19.89** 
PQ 49.16 ± 1.44 57.83 ± 7.36 79.25 ± 4.25††† 53.58 ± 5.03 69.31 ± 6.11† 72.48 ± 19.23††† 
QRS 10.80 ± 0.23 10.00 ± 0.48 14.41 ± 1.03†† 13.83 ± 1.18* 12.00 ± 0.51* 14.91 ± 0.81 
QTc90 25.37 ± 2.07 20.61 ± 1.51† 37.69 ± 5.37 24.61 ± 1.54 24.55 ± 0.56* 25.77 ± 0.91* 
Last week of Follow-Up 
 
RR 129.73 ± 6.24 119.43 ± 3.47 137.96 ± 2.58 240.37 ± 37.12*  201.41 ± 50.19** ‡   301.59 ± 29.51***‡
PQ 45.66 ± 3.01 60.01 ± 3.34†† 78.66 ± 3.78††† 67.41 ± 6.19* 86.34 ± 5.44*** † ‡ 98.75 ± 8.46* † ‡ 
QRS 10.5 ± 0.32 10.91 ± 0.92 12.33 ± 0.47† 13.9 ± 1.37* 14.31 ± 0.41** ‡‡       20.75 ± 1.07*** †† ‡ 
QTc90 21.83 ± 2.38 22.36 ± 3.19 23.24 ± 4.61 25.52 ± 2.14 24.25 ± 2.03 24.53 ± 2.17 
 
 
 
*, P<0.05; **, P<0.01; ***, P<0.001 (Wild-type vs Zmpste24-/-) 
†, P<0.05; ††, P<0.01; †††, P<0.001 (vs Baseline)  
‡, P<0.05; ‡‡, P<0.01; P<0.001 (‡ First vs Last week of follow-up) 
 
 
Mice were given a weekly β-adrenergic challenge with isoproterenol starting at 11 weeks of age 
(First week of Follow-Up) and until 19 weeks of age or death of the animal (Last week of Follow-
Up). Surface ECG analyses comparing fundamental rhythm parameters were performed in 
anesthetized WT and Zmpste24-/- mice at baseline, after adrenergic challenge with isoproterenol 
(ISO) and during recovery. 
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 TABLE S4. Electrophysiological parameters of transmembrane action potentials recorded ex 
vivo in ventricular multicellular preparations 
 
 
 
Tissue Mice (n=5) BCL (ms) 
Frequency 
(Hz) 
RMP 
(mV) 
Vmax 
(V/s) 
APA 
(mV) 
APD20 
(ms) 
APD50 
(ms) 
APD90 
(ms) 
Right 
ventricle 
Wild-type 258±31 4.8±0.6 -80.1±1.9 231±10 115.8±2.5 11.6±2.1 35.9±6.2 126±14
Zmpste24 -/- 265±26 4.2±0.5 -77.1±1.2 217±17 117.3±1.9 12.7±1.1 41.3±1.7 120±6 
Left 
ventricle 
Wild-type Stimulated 3 -77.6±1.0 229±3.5 121.5±1.7 9.6±0.7 41.3±1.9 136±7
Zmpste24 -/- 310±24 3.2±0.2 -82.8±2.5 260±7.4 121.2±1.2 13.3±1.2 39.4±2.6 121±5 
 
 
 
BCL: Basic cycle length expressed in milliseconds (ms) 
RMP: Resting membrane potential expressed in millivolts (mV) 
Vmax: Maximum velocity of depolarization 
APA: Action potential amplitude 
APD: Action potential duration measured at indicated % of repolarization and expressed in ms 
 
